Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase.

Clémentine VabreKyle Johnson François MontastrucDelphine VezzosiOriana H YuChristel Renoux

Published in: European journal of clinical pharmacology (2023)

TT was associated with a greater risk of reports of osteonecrosis compared to use of any other drug and use of drugs for BPH. This signal should be confirmed in complementary studies.

Keyphrases

adverse drug
drug induced
replacement therapy
benign prostatic hyperplasia
case control
electronic health record